KR830007505A - Process for preparing phenylalkylamine - Google Patents

Process for preparing phenylalkylamine Download PDF

Info

Publication number
KR830007505A
KR830007505A KR1019810004912A KR810004912A KR830007505A KR 830007505 A KR830007505 A KR 830007505A KR 1019810004912 A KR1019810004912 A KR 1019810004912A KR 810004912 A KR810004912 A KR 810004912A KR 830007505 A KR830007505 A KR 830007505A
Authority
KR
South Korea
Prior art keywords
group
carbon atoms
formula
compound
process according
Prior art date
Application number
KR1019810004912A
Other languages
Korean (ko)
Other versions
KR870000183B1 (en
Inventor
켁 요하네스
피이퍼 헬무트
크뤼거 게르트
놀 클라우스
댐겐 위르겐
카다쯔 루돌프
디이데렌 빌리
Original Assignee
하인쯔 쉐플러 프리쯔 좀 머
닥터 칼 토메 게젤샤프트 미트 베슈랭크터 하프퉁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인쯔 쉐플러 프리쯔 좀 머, 닥터 칼 토메 게젤샤프트 미트 베슈랭크터 하프퉁 filed Critical 하인쯔 쉐플러 프리쯔 좀 머
Publication of KR830007505A publication Critical patent/KR830007505A/en
Application granted granted Critical
Publication of KR870000183B1 publication Critical patent/KR870000183B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11BINFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B23/00Record carriers not specific to the method of recording or reproducing; Accessories, e.g. containers, specially adapted for co-operation with the recording or reproducing apparatus ; Intermediate mediums; Apparatus or processes specially adapted for their manufacture
    • G11B23/02Containers; Storing means both adapted to cooperate with the recording or reproducing means
    • G11B23/04Magazines; Cassettes for webs or filaments
    • G11B23/08Magazines; Cassettes for webs or filaments for housing webs or filaments having two distinct ends
    • G11B23/087Magazines; Cassettes for webs or filaments for housing webs or filaments having two distinct ends using two different reels or cores
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11BINFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B25/00Apparatus characterised by the shape of record carrier employed but not specific to the method of recording or reproducing, e.g. dictating apparatus; Combinations of such apparatus
    • G11B25/06Apparatus characterised by the shape of record carrier employed but not specific to the method of recording or reproducing, e.g. dictating apparatus; Combinations of such apparatus using web-form record carriers, e.g. tape
    • G11B25/066Apparatus characterised by the shape of record carrier employed but not specific to the method of recording or reproducing, e.g. dictating apparatus; Combinations of such apparatus using web-form record carriers, e.g. tape adapted for use with containers of different sizes or configurations; adaptor devices therefor

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

내용 없음No content

Description

페닐알킬아민의 제조방법Process for preparing phenylalkylamine

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (26)

a) 일반식(Ⅱ)의 화합물을 환원시키거나,a) reducing the compound of formula (II), or b) 반응혼합물중에 임의로 제조된 일반식(Ⅲ)의 카보닐 화합물 또는 그의 알데히드 하이드레이트를 일반식(Ⅳ)의 아민 및 환원제와 반응시키거나,b) reacting a carbonyl compound of formula (III) or an aldehyde hydrate thereof optionally prepared in the reaction mixture with an amine and a reducing agent of formula (IV), or c) 일반식(Ⅴ)중의 1개이상의 보호잔기를 제거시키거나,c) removing one or more protective residues of formula (V), or d) R2또는 R3잔기중의 하나가 수소원자를 나타내는 일반식(Ⅰ)의 화합물을 제조하기 위해서는 일반식(Ⅵ)의 화합물을 탈활로 겐화시키거나,d) degenerated the compound of formula (VI) to prepare a compound of formula (I) wherein one of the R 2 or R 3 residues represents a hydrogen atom, or e) 일반식(Ⅶ)의 화합물을 알킬화시키거나,e) alkylating a compound of formula (VII), or f) R1이 탄소원자 1 내지 3개의 알카노일 그룹 또는 탄소원자 2 내지 4개의 알콕시카보닐 그룹으로 치환된 아미노그룹을 나타내고, R5는수소원자를 나타내지 않는 일반식(Ⅰ)의 화합물을 제조하기 위해서는, 일반식(Ⅷ)의 화합물을 일반식(Ⅸ)의 화합물로 알킬화시키거나,f) R 1 represents an amino group substituted with an alkanoyl group having 1 to 3 carbon atoms or an alkoxycarbonyl group having 2 to 4 carbon atoms, and R 5 is a compound of formula (I) which does not represent a hydrogen atom. In order to do this, the compound of the formula (VIII) is alkylated with a compound of the formula (VIII), g) D가 설피닐 또는 설포닐 그룹을 나타내는 일반식(Ⅰ)의 화합물을 제조하기 위해서는 일반식(Ⅹ)의 화합물을 산화시키거나,g) in order to prepare a compound of formula (I) wherein D represents a sulfinyl or sulfonyl group, h) D가 산소 또는 황원자를 나타내고, R5가 수소원자를 나타내지는 않는 일반식(Ⅰ)의 화합물을 제조하기 위해서는 일반식(XI)의 화합물을 일반식(XII)의 화합물 또는 그의 알칼리 염 또는 알카리토금속염과 반응시키고, 따라서 수득된 1,2 또는 3개의 광학적 활성 탄소원자를 함유하는 일반식(Ⅰ) 화합물은 계속하여 그의 광학적 활성 대장체, 그의 디아스테레오이머 라세메이트 및 그의 광학적 대장체로 분리시키고/시키거나 따라서 수득된 일반식(Ⅰ)의 화합물을 그의 생리학적으로 허용되는 무기 또는 유기산과의 염으로 전환시킴을 특징으로 하여 일반식(Ⅰ)의 페닐알킬아민을 제조하는 방법.h) To prepare a compound of formula (I) wherein D represents an oxygen or sulfur atom and R 5 does not represent a hydrogen atom, the compound of formula (XI) may be a compound of formula (XII) or an alkali salt thereof or The compound of general formula (I) containing 1,2 or 3 optically active carbon atoms thus obtained is reacted with an alkaline earth metal salt, and subsequently separated into its optically active colon, its diastereomeric racemate and its optical colon. And / or thus converting the obtained compound of formula (I) into a salt with its physiologically acceptable inorganic or organic acid. 상기식중In the above meal R1은 하이드록시그룹, 탄소원자 1 내지 3개의 알카노일그룹 또는 탄소원자 2 내지 4개의 알콕시카보닐 그룹으로 임의 치환된 아미노그룹, 알킬아미노 또는 디알킬아미노 그룹(이때 각알킬부분은 탄소원자 1 내지 3개를 함유하며, 각기 페닐그룹으로 치환될 수 있음)을 나타내며,R 1 is an amino group, alkylamino or dialkylamino group optionally substituted with a hydroxy group, an alkanoyl group having 1 to 3 carbon atoms or an alkoxycarbonyl group having 2 to 4 carbon atoms, where each alkyl moiety is a carbon atom 1 To 3, each of which may be substituted with a phenyl group). R2및 R3는 동일 또는 상이하며, 할로겐원자, 트리플루오로메틸, 시아노 또는 니트로그룹을 나타내거나 R2및 R3중의 하나가 수소원자를 나타내며,R 2 and R 3 are the same or different and represent a halogen atom, trifluoromethyl, cyano or nitro group or one of R 2 and R 3 represents a hydrogen atom, R4는 수소원자 또는 탄소원자 1 내지 3개의 알킬그룹을 나타내고,R 4 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, R5는 수소원자, 탄소원자 1 내지 4개의 직쇄 또는 측쇄 알킬그룹, 탄소원자 3 내지 6개의 사이클로알킬그룹, 탄소원자 2 내지 5개의 알케닐그룹 또는 탄소원자 7내지 10개의 아르알킬그룹을 나타내며,R 5 represents a hydrogen atom, a linear or branched alkyl group of 1 to 4 carbon atoms, a cycloalkyl group of 3 to 6 carbon atoms, an alkenyl group of 2 to 5 carbon atoms, or an aralkyl group of 7 to 10 carbon atoms, A는 메틸렌,에틸렌 또는 하이드록시 메틸렌그룹을 나타내고,A represents methylene, ethylene or hydroxy methylene group, B는 다음 일반식B is the following general formula 또는or 의 그룹을 나타내며,Represents a group of, R6는 수소 또는 할로겐원자, 하이드록시 그룹, 페닐 그룹으로 임의 치환된 탄소원자 1 내지 3개의 알콕시그룹, 탄소원자 각기 1 내지 3개의 알킬설페닐 또는 알킬설피닐 그룹을 나타내고,R 6 represents hydrogen or a halogen atom, a hydroxy group, an alkoxy group having 1 to 3 carbon atoms optionally substituted with a phenyl group, an alkylsulphenyl or alkylsulfinyl group having 1 to 3 carbon atoms each, R7은 수소원자, 하이드록시 그룹 또는 탄소원자1 내지 3개의 알콕시그룹을 나타내거나, R6및 R7이 함께 메틸렌디옥시 그룹을 나타내며,R 7 represents a hydrogen atom, a hydroxy group or an alkoxy group having 1 to 3 carbon atoms, or R 6 and R 7 together represent a methylenedioxy group, R8은 수소원자 또는 탄소원자 1 내지 3개의 알킬그룹을 나타내고,R 8 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, D는 산소 또는 황원자, 설피닐 또는 설포닐그룹을 나타내며,D represents an oxygen or sulfur atom, sulfinyl or sulfonyl group, n은 1 또는 2를 나타내고n represents 1 or 2 E는 탄소원자 각기 1 내지 3개의 알킬그룹 1개 또는 2개로 임의 치환된 탄소원자 3 내지 5개의 직쇄 알킬렌그룹을 나타내거나, 단 A가 메틸렌 또는 에틸렌 그룹을 나타내고 및/또는 R1이 탄소원자 1 내지 3개으 알카노일그룹 또는 탄소원자 2 내지 4개의 알콕시캅닐그룹으로 치환된 아미노그룹, 하이드록시, 알킬아미노 또는 디알킬아미노그룹(이때 알킬부분은 각기 탄소원자 1 내지 3개를 함유할 수 있으며, 각기 페닐그룹에 의해 치환될 수 있음)을 나타내고 및/또는 R2가 트리플루오로메틸, 시아노 또는 니트로 그룹을 나타내며, 및/또는 R3가 불소원자를 나타내고, 및/또는 R4가 탄소원자 1 내지 3개의 알킬그룹을 나타내며, 및/또는 R5가 탄소원자 1 내지 4개의 알킬그룹, 탄소원자 3 내지 6개의 사이클로알킬그룹, 탄소원자 2 내지 5개의 알케닐 그룹 또는 탄소원자 7 내지 10개의 아르알킬 그룹을 나타내고, 및 또는 R6는 불소 또는 염가원자, 탄소원자 각기 1 내지 3개의 알킬설페닐 또는 알킬설포닐 그룹을 나타낼 경우에는 에틸렌그룹을 나타내거나 A가 메틸렌그룹을 나타낼 경우에는 일반식의 그룹(이때 R9은 탄소원자 1 내지 3의 알킬그룹을 나타냄)을 또한 나타내며,E represents a straight chain alkylene group of 3 to 5 carbon atoms optionally substituted with 1 or 2 alkyl groups of 1 to 3 carbon atoms each, provided that A represents a methylene or ethylene group and / or R 1 represents a carbon atom Amino groups, hydroxy, alkylamino or dialkylamino groups substituted with 1 to 3 alkanoyl groups or 2 to 4 alkoxycapnyl groups, wherein the alkyl moieties may each contain 1 to 3 carbon atoms Each of which may be substituted by a phenyl group) and / or R 2 represents a trifluoromethyl, cyano or nitro group, and / or R 3 represents a fluorine atom, and / or R 4 represents carbon atom 1-3 alkyl denotes a group, and / or R 5 is alkyl of 1 to 4 carbon atoms group, the carbon atom 3 to 6 cycloalkyl groups, the carbon atoms 2 to 5 alkenyl group, or It wishes chair represents the 7 to 10 aralkyl groups, and or R 6, if represent fluorine or a discount atoms, carbon atoms, each with 1 to 3 alkyl sulfonic phenyl or alkylsulfonyl group represents an ethylene group, or A is a methylene group In the case of Also represents a group of wherein R 9 represents an alkyl group of from 1 to 3 carbon atoms, X는 다음 일반식의 그룹을 나타내고,X represents a group of the following general formula, 또는 or 이때 R4는 전술한 바와 같고, 아실은 유기 아실그룹을 나타내고, Z는 환원에 의해 제거될 수 있는 그룹을 나타내며,Wherein R 4 is as described above, acyl represents an organic acyl group, Z represents a group that can be removed by reduction, K는 잔기 L중 알킬부분에 위치하고 K와 인접한 수소와 함께 산소를 나타내고(즉 잔기 L중의 알킬부분에 위치하는 K와 인접한 수소는 탄소-산소 이중결합중의 단일결합으로 바뀜)K represents oxygen with hydrogen adjacent to K located in the alkyl moiety of residue L (ie hydrogen adjacent to K located in alkyl moiety in residue L is replaced by a single bond in a carbon-oxygen double bond) L은 B에서 정의된 바와 같거나 수소원자를 제외하고는 R5에서 정의돈 바와 같거나 다음 일반식의 그룹을 나타내며L is as defined in B or excluding hydrogen atoms, or as defined in R 5 or represents a group of the general formula (이때 R1내지 R4는 전술된 바와 같고, A´는 카보닐, 메틸렌 또는 에틸렌그룹을 나타냄)Wherein R 1 to R 4 are as described above and A 'represents a carbonyl, methylene or ethylene group. M 및 Q는 서로 상이하고, B 및 R5에서 전술된 바와 같거나, 잔기 M 또는 Q중의 하나가 다음 일반식의 그룹을 나타내며,M and Q are different from each other, as described above in B and R 5 , or one of the residues M or Q represents a group of the general formula (이때 R1내지 R4및 A는 전술된 바와 같음)Wherein R 1 to R 4 and A are as described above R1´는 R1에서 전술된 바와 같거나 보호잔기로 보호된 하이드록시 또는 아미노 그룹을 나타내며,R 1 ′ represents a hydroxy or amino group as described above for R 1 or protected with a protecting moiety, A˝는 A에서 전술된 바와 같거나 보호잔기로 보호된 하이드록시 메틸렌 그룹을 나타내고,A 'represents a hydroxy methylene group as described above in A or protected with a protective moiety, R5´는 R5에서 전술된 바와 같거나 아미노그룹 보호잔기를 나타내며,R 5 ′ are the same as described above for R 5 or represent an amino group protecting moiety, B´는 B에서 전술된 바와 같거나 다음 일반식의 그룹을 나타낸다.B 'is as described above in B or represents a group of the following general formula. 또는or 이때At this time R8, D, E 및 n은 전술된 바와 같고,R 8 , D, E and n are as described above, R6´ 및 R7´는 동일 또는 상이하며,R 6 ′ and R 7 ′ are the same or different, R6및 R7에서 전술된 바와 같거나 보호잔기로 보호된 하이드록시 그룹을 나타내며,Or a hydroxy group as described above for R 6 and R 7 or protected with a protecting moiety; R1´, A˝, R5´ 및/또는 B´잔기중 적어도 하나는 장기 상기언급된 보호잔기중의 하나를 함유하여야 하고 Hal은 염소, 브롬 또는 요오드원자를 나타내며,At least one of the residues R 1 ′, A ′, R 5 ′ and / or B ′ should contain one of the abovementioned protective residues and Hal represents a chlorine, bromine or iodine atom, R5˝는 R5에서 전술된 바와 같거나 수소원자를 나타내며,R 5 ' is the same as described above for R 5 or represents a hydrogen atom, B˝는 B에서 전술된 바와 같고 이 때 R5˝가 수소원자를 나타내지 않을 경우에는 R6또는 R7잔기중 적어도 하나가 수소를 나타내야 하거나 R1이 탄소원자 1 내지 3의 알킬그룹으로 임의 치환된 아미노그룹을 나타내야 하며, 이때 알킬그룹을 페놀잔기로 임의 치환될 수 있으며,B 'is as described above in B, and when R 5' does not represent a hydrogen atom, at least one of R 6 or R 7 residues must represent hydrogen or R 1 is optionally substituted with an alkyl group having 1 to 3 carbon atoms. To the amino group, wherein the alkyl group may be optionally substituted with phenol residues, R10은 수소원자, 메틸 또는 에틸그룹 또는 탄소원자 1 내지 3개의 알콕시그룹을 나타내고,R 10 represents a hydrogen atom, a methyl or ethyl group or an alkoxy group having 1 to 3 carbon atoms, Y는 친핵성 치환가능 그룹을 나타내고,Y represents a nucleophilic substitutable group, m은 0 또는 1을 나타내며,m represents 0 or 1, V는 친핵성 치환가능 그룹을 나타내며,V represents a nucleophilic substitutable group, A˝´은 메틸렌 또는 에틸렌 그룹을 나타내고,A 'represents a methylene or ethylene group, D´는 산소 또는 황원자를 나타낸다.D 'represents an oxygen or sulfur atom. 제1항의 a) 내지 d), g) 또는 h)에 있어서, 반응을 용매중에서 시행하는 방법.The process according to claim 1 a) to d), g) or h), wherein the reaction is carried out in a solvent. 제1항의 a) 또는 2항에 있어서, 환원 반응을 하이드리드, 1급 또는 2급 알콜 존재하의 알루미늄 이소프로필레이트, 촉매적으로 활성화돈 수소 또는 발생기 수소와 함께 시행하는 방법.The process according to claim 1 a) or 2, wherein the reduction reaction is carried out with aluminum isopropylate in the presence of a hydride, primary or secondary alcohol, catalytically activated donor or generator hydrogen. 제1항의 a), 2항 또는 3항에 있어서, 반응을 -20℃ 내지 반응혼합물의 비등온도 예를들면 -20 내지 100℃에서 시행하는 방법.The process according to claim 1 a), 2 or 3, wherein the reaction is carried out at -20 ° C to the boiling temperature of the reaction mixture, for example -20 to 100 ° C. 제1항의 a), 2항 내지 4항중의 어느 하나에 있어서, A가 하이드록시 메틸렌 그룹을 나타내는 일반식(Ⅰ)의 화합물을 제조하기 위해 금속 콤플렉스 하이드리드, 알루미늄 이소프로필레이트, 촉매적으로 활성화된 수소 또는 발생기 수소로 환원시키는 방법.The metal complex hydride, aluminum isopropylate, catalytically activated according to any one of claims 1 to 6, in which A represents a compound of general formula (I) wherein A represents a hydroxy methylene group. To reduced hydrogen or generator hydrogen. 제1항의 a) 2항 내지 4항중의 어느하나에 있어서, A가 메틸렌 또는 에틸렌 그룹을 나타내는 일반식(Ⅰ)의 화합물을 제조하기 위해 나트륨 보로하이드리드, 나트륨 시아노보로하이드리드 또는 리듐알루미늄 하이드리드와 같은 금속 콤플렉스 하이드리드 또는 피리딘-보란으로 환원시키는 방법.Sodium borohydride, sodium cyanoborohydride or lithium aluminum hydride according to any one of claims 1 to 4 for preparing a compound of general formula (I) in which A represents methylene or ethylene group. Reduction with a metal complex hydride or pyridine-borane such as lead. 제1항의 b) 또는 2항에 있어서, 환원제로써 금속 콤플렉스 하이드리드 또는 촉매적으로 활성화된 수소를 사용하는 방법.The process according to claim 1 b) or 2, wherein a metal complex hydride or catalytically activated hydrogen is used as the reducing agent. 제1항의 b) 또는 2항에 있어서, 메틸화에 포름산을 환원제로써 사용하는 방법.The process according to claim 1 b) or 2, wherein formic acid is used as the reducing agent in methylation. 제1항의 b) 또는 2항내지 7항중의 어느 하나에 있어서, 반응을 -20 내지 100℃ 온도에서 시행하는 방법.The process according to claim 1 b) or 2 to 7, wherein the reaction is carried out at a temperature of -20 to 100 ° C. 제1항의 b) 또는 8항에 있어서, 반응을 반응혼합물의 비등온도에서 시행하는 방법.The process of claim 1 b) or 8 wherein the reaction is carried out at the boiling temperature of the reaction mixture. 제1항의 c) 또는 2항에 있어서, 보호그룹으로 사용된 아실그룹을 산 또는 염기로 가수분해하여 제거시키는 방법.The process according to claim 1 c) or 2, wherein the acyl group used as the protecting group is removed by hydrolysis with an acid or a base. 제1항의 c) 또는 2항에 있어서, 보호그룹으로 사용된 벤질그룹을 가수소분해하여 제거시키는 방법.The process according to claim 1 c) or 2, wherein the benzyl group used as the protecting group is removed by hydrogenolysis. 제1항의 d) 또는 2항에 있어서, 탈할로겐화를 트리페닐포스핀, 수소화 촉매존재하의 수소 또는 금속 콤플렉스하이드리드와 함께 시행하는 방법.The process according to claim 1 d) or 2, wherein the dehalogenation is carried out with triphenylphosphine, hydrogen in the presence of a hydrogenation catalyst or metal complex hydride. 제1항의 d), 2항 내지 13항중의 어느하나에 있어서, 탈할로겐화를 0 내지 150℃ 온도에서 시행하는 방법.The method according to any one of claims 1 to 2, wherein the dehalogenation is carried out at a temperature of 0 to 150 ° C. 제1항의 e)에 있어서, 질소원자의 알킬화를 상응하는 알킬 할로게나이드 또는 알킬설페이트, 상응하는 카보닐화합물 및 금속 콤플렉스 하이드리드 또는 포름알데히드/포름산과 함께 시행하는 방법.The process according to claim 1, wherein the alkylation of the nitrogen atom is carried out with the corresponding alkyl halogenide or alkyl sulfate, the corresponding carbonyl compound and the metal complex hydride or formaldehyde / formic acid. 제1항의 e)에 있어서, 페놀성 하이드록시 그룹의 알킬화를 상응하는 알킬 할로 게나이드, 알킬설페이트 또는 디아조 알칸과 함께 시행하는 방법.The process according to claim 1, wherein the alkylation of the phenolic hydroxy group is effected with the corresponding alkyl halogenide, alkylsulfate or diazo alkanes. 제1항의 e), 15항 내지 16항중의 어느 하나에 있어서 반응을 염기 및 용매조재하에 시행하는 방법.The process according to any one of claims 1 to 15, wherein the reaction is carried out in the presence of a base and a solvent. 제1항의 e) 15항 내지 17항중의 어느 하나에 있어서, 반응을 -10 내지 50℃의 온도에서 시행하는 방법.The process according to any one of claims 1 to 15, wherein the reaction is carried out at a temperature of -10 to 50 ° C. 제1항의 f)에 있어서, 반응을 염기 및 용매존재하에 시행하는 방법.The process according to claim 1, wherein the reaction is carried out in the presence of a base and a solvent. 제1항의 f) 또는 19항에 있어서, 반응을 0 내지 100℃의 온도에서 시행하는 방법.The process of claim 1 f) or 19, wherein the reaction is carried out at a temperature of from 0 to 100 ° C. 제1항의 g) 또는 2항에 있어서, D가 설피닐 그룹을 나타내는 일반식(Ⅰ)의 화합물을 제조하기 위해서 산화반응을 동몰량의 산화제와 함께 시행하는 방법.The process according to claim 1 g) or 2, wherein the oxidation reaction is carried out with an equimolar amount of oxidizing agent to produce a compound of formula (I) wherein D represents a sulfinyl group. 제1항의 g) 또는 2항에 있어서, D가 설포닐 그룹을 나타내는 일반식(Ⅰ)의 화합물을 제조하기 위해서 산화반응을 과량의 산화제와 함께 시행하는 방법.The process according to claim 1 or 2, wherein the oxidation reaction is carried out with an excess of oxidizing agent to produce a compound of formula (I) wherein D represents a sulfonyl group. 제1항의 g), 2항, 20항 또는 22항에 있어서, 산화반응을 -80 내지 100℃의 온도에서 시행하는 방법.The method according to claim 1, 2, 20 or 22, wherein the oxidation reaction is carried out at a temperature of -80 to 100 ° C. 제1항의 h)에 있어서, 반응을 알카리 염기 존재하에 시행하는 방법.The method of claim 1, wherein the reaction is carried out in the presence of an alkali base. 제1항의 h) 또는 24항에 있어서 반응을 -10 내지 100℃ 바람직하게는 0 내지 50℃의 온도에서 시행하는 방법.Process according to claim 1 h) or 24, wherein the reaction is carried out at a temperature of -10 to 100 ° C, preferably 0 to 50 ° C. 제1항의 h), 24항 또는 25항에 있어서, 반응을 용매 중에서 시행하는 방법.The process according to claim 1 h), 24 or 25, wherein the reaction is carried out in a solvent. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019810004912A 1980-12-10 1981-12-10 Process for the preparation of phenylalkylamines KR870000183B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3046465.4 1980-12-10
DE3046465 1980-12-10

Publications (2)

Publication Number Publication Date
KR830007505A true KR830007505A (en) 1983-10-21
KR870000183B1 KR870000183B1 (en) 1987-02-14

Family

ID=6118763

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810004912A KR870000183B1 (en) 1980-12-10 1981-12-10 Process for the preparation of phenylalkylamines

Country Status (32)

Country Link
JP (1) JPS57122048A (en)
KR (1) KR870000183B1 (en)
AR (1) AR227802A1 (en)
AT (1) AT379378B (en)
AU (1) AU547655B2 (en)
BE (1) BE891416A (en)
CA (1) CA1202636A (en)
CH (1) CH651541A5 (en)
CS (1) CS229924B2 (en)
DD (1) DD202867A5 (en)
DE (1) DE3146623A1 (en)
DK (1) DK541981A (en)
ES (4) ES507635A0 (en)
FI (1) FI813934L (en)
FR (1) FR2498596B1 (en)
GB (1) GB2088873B (en)
GR (1) GR77323B (en)
HU (1) HU185676B (en)
IE (1) IE52007B1 (en)
IL (1) IL64498A (en)
IT (1) IT1172129B (en)
LU (1) LU83830A1 (en)
NL (1) NL8105170A (en)
NO (1) NO152649C (en)
NZ (1) NZ199215A (en)
PH (1) PH21599A (en)
PL (1) PL129385B1 (en)
PT (1) PT74112B (en)
SE (1) SE8107387L (en)
SU (1) SU1172449A3 (en)
YU (1) YU290381A (en)
ZA (1) ZA818529B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720586A (en) * 1983-12-06 1988-01-19 Fisons, Plc Substituted 3,4-dihydroxy-phenylethylamino compounds
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
US4943591A (en) * 1984-10-17 1990-07-24 Glaxo Group Limited Dichloroaniline derivatives
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
GB8603475D0 (en) * 1986-02-12 1986-03-19 Glaxo Group Ltd Chemical compounds
US4959381A (en) * 1987-02-10 1990-09-25 Glaxo Group Limited Pyridine compounds which have useful activity associated with reversible air ways obstruction
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
US4906645A (en) * 1988-09-12 1990-03-06 Merck & Co., Inc. Pyridyl aminoethanol compounds with growth promotion and an increase in feed efficiency
DE4028398A1 (en) * 1990-09-07 1992-03-12 Thomae Gmbh Dr K PHENYLETHANOLAMINES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
WO1993007113A1 (en) * 1991-10-04 1993-04-15 Taisho Pharmaceutical Co., Ltd. Alkoxyphenylalkylamine derivative
US8349898B2 (en) * 2008-11-18 2013-01-08 Wisconsin Alumni Research Foundation Sigma-1 receptor ligands and methods of use
GB201208775D0 (en) * 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds
US11999676B2 (en) 2016-04-21 2024-06-04 University Of Kentucky Research Foundation Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
US10668030B2 (en) * 2016-04-21 2020-06-02 University Of Kentucky Research Foundation Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
WO2023235153A1 (en) * 2022-05-31 2023-12-07 Corteva Agriscience Llc Crystalline forms of picolinamide fungicide compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618007A1 (en) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Process for the production of new amino-monohalophenylaethanolamines
DE2351281C3 (en) * 1973-10-12 1981-07-30 Dr. Karl Thomae Gmbh, 7950 Biberach Aminophenylethanolamine derivatives, their production and use
NL176168C (en) * 1972-12-18 1985-03-01 Thomae Gmbh Dr K PROCEDURE FOR THE PREPARATION OR MANUFACTURE OF A PHARMACEUTICAL PREPARATION AND METHOD FOR THE PREPARATION OF USEFUL NEW SUBSTITUTED 1-(4-AMINOPHENYL)-2-AMINO-ETHANOL DERIVATIVES WHICH, EXCEPT AN ANALGETIC, UTERUS SPASMOLYTIC AND ANTI-SPASTIC ACTIVITY, HAVE RELATIVE STRIPES IN PARTICULAR HAVE A BETA2 MIMETIC AND/OR BETA1 BLOCKING ACTIVITY.
GB1523974A (en) * 1975-02-05 1978-09-06 Yamanouchi Pharma Co Ltd 4-substituted amino- -aminomethylbenzyl alcohol derivatives
JPS51125232A (en) * 1975-02-05 1976-11-01 Yamanouchi Pharmaceut Co Ltd Process for preparing 4-substituted amido-3,5-dihalogeno-alpha-substituted aminomethylbenzyl alcohols
EP0006961A1 (en) * 1978-02-21 1980-01-23 Sandoz Ag New phenylethylamines, process for their preparation, and pharmaceutical compositions containing them
IL57670A (en) * 1978-07-03 1982-11-30 Lilly Co Eli Phenethanolamines,their preparation and pharmaceutical formulations comprising them

Also Published As

Publication number Publication date
FR2498596B1 (en) 1986-03-21
PT74112A (en) 1982-01-01
CS229924B2 (en) 1984-07-16
CA1202636A (en) 1986-04-01
YU290381A (en) 1983-10-31
ZA818529B (en) 1983-08-31
PT74112B (en) 1984-10-09
IL64498A0 (en) 1982-03-31
HU185676B (en) 1985-03-28
ES512914A0 (en) 1983-03-01
AR227802A1 (en) 1982-12-15
AU547655B2 (en) 1985-10-31
ES8304538A1 (en) 1983-03-01
IE52007B1 (en) 1987-05-13
AU7841481A (en) 1982-09-23
NO152649B (en) 1985-07-22
NO152649C (en) 1985-10-30
ES512913A0 (en) 1983-03-01
DE3146623A1 (en) 1982-07-15
BE891416A (en) 1982-06-09
PL129385B1 (en) 1984-05-31
IT8149853A0 (en) 1981-12-07
IL64498A (en) 1985-08-30
KR870000183B1 (en) 1987-02-14
ES8301890A1 (en) 1983-01-01
FI813934L (en) 1982-06-11
AT379378B (en) 1985-12-27
NO814194L (en) 1982-06-11
DK541981A (en) 1982-06-11
LU83830A1 (en) 1983-04-13
ES8304536A1 (en) 1983-03-01
ES507635A0 (en) 1983-01-01
SU1172449A3 (en) 1985-08-07
NL8105170A (en) 1982-07-01
IE812888L (en) 1982-06-10
DD202867A5 (en) 1983-10-05
NZ199215A (en) 1986-07-11
PL234155A1 (en) 1982-08-02
ES8304537A1 (en) 1983-03-01
IT1172129B (en) 1987-06-18
GB2088873B (en) 1984-10-17
GR77323B (en) 1984-09-11
PH21599A (en) 1987-12-11
SE8107387L (en) 1982-07-26
ES512915A0 (en) 1983-03-01
GB2088873A (en) 1982-06-16
ATA512981A (en) 1985-05-15
CH651541A5 (en) 1985-09-30
FR2498596A1 (en) 1982-07-30
JPS57122048A (en) 1982-07-29

Similar Documents

Publication Publication Date Title
KR830007505A (en) Process for preparing phenylalkylamine
KR840009063A (en) Method for preparing phenethanolamine derivative
KR830010077A (en) Method for Preparing Benzazepine Derivatives
KR850008162A (en) Method for preparing aminotetraline derivatives
US4261922A (en) Process for alkoxylation of phenols
AR241704A1 (en) Procedure for preparing new derivatives of arylphenylether and salts thereof.
ES2161452T3 (en) PROCEDURE FOR THE PREPARATION OF BENCILIC ETERS.
KR840004725A (en) Preparation method of ether compound and composition of insecticide and tick repellent containing the compound
KR840001145A (en) Method for preparing amino compound of pyridazine
KR850004476A (en) Method for preparing 2-phenyl-imidazole
KR840000508A (en) Method for preparing 4-anilinopyrimidine derivative
KR850008666A (en) Method for preparing substituted bis- (4-aminophenyl) -sulfone
KR850008667A (en) Method for preparing benz azepine derivative
KR850005440A (en) Method for producing a bactericide containing thiazole and oligoether groups
PE20001366A1 (en) METHOD FOR THE PREPARATION OF ARYL ETHERS
PT83449B (en) PROCESS FOR N-ALKYLACACA DI DIHYDROLYSERGIC ACID
KR950032103A (en) Method for preparing 4,4'-dinitrostilbene-2,2'-disulfonic acid and salts thereof
KR840001141A (en) Method for preparing substituted azolyl-phenoxy derivatives
KR840009078A (en) Process for preparing new 1- [2-carbethoxy 4-benz alkyl amido phenoxy] -3-amino-2-propanol
KR850006395A (en) Method for preparing a glycidyl compound
KR860001108A (en) Method for preparing phenyl-naphthyridine
KR860008135A (en) Process for producing amino ketone derivatives
PL100236B1 (en) METHOD OF THE PRODUCTION OF 5-FLUORO-2-METHYL-1- / P-METHYLSULFINYLBENZYLIDENO / -INDENOACETIC-3
PT85345B (en) PREPARED PROCESS FOR THE PREPARATION OF 5,6-SUBSTITUTED 2,4-KINAZOLINODIAMINS
KR950018011A (en) Improved Synthesis Method of Bisindoleylmaleimide

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right